Interestingly, TGF-β blockade significantly delayed tumor outgrowth of both KPC3 and MC38 tumors, but only when TGF-β blockade was started early after tumor challenge (Fig. 1C and D) and not when tumors were already established (Supplementary Fig. S2A). The gene discussed is TGFB1; the disease is neoplasm.